STAMPEDE2 Recruits First Patient

We are delighted to announce that the STAMPEDE2 trial recruited its first patient at the Royal Marsden Hospital Sutton on Friday 21^st June.

The patient was recruited into Comparison P which is testing the addition of PSMA-Lutetium to standard care.

We are full steam ahead trying to activate as many sites as possible across the UK and aim to recruit up to 5000 patients over the next 5 years.

Many thanks to everyone involved.